GSAM 2024 Annual Conference

No products in the cart.

GSAM 2024 Annual Conference

No products in the cart.

Addiction Medicine Updates

Home Archive "Addiction Medicine Updates"
Bill removes mandated report to law enforcement of positive drug tests in newborns
Addiction Medicine Updates Legislation

Bill Removes Mandated Report to Law Enforcement of Positive Drug Tests in Newborn

Bill removes mandated report to law enforcement of positive drug tests in newborns By Catrina Petersen | The Center Square (The Center Square) – The legislature is ready to send a bill to Illinois Gov. J.B. Pritzker that removes the mandate that the Department of Children and Family Services must report newborn babies’ positive toxicology screens to law enforcement. Senate Bill 3136...
Doctors-and-Pharmacists-Groups-Send-Joint-Letter-to-DEA,-HHA,-ONDCP,-and-SAMHSA-on-Buprenorphine-Access-Issues
Addiction Medicine Updates Legislation

Doctors and Pharmacists Groups Send Joint Letter to DEA, HHA, ONDCP, and SAMHSA on Buprenorphine Access Issues:

Today, the American Society of Addiction Medicine (ASAM) joined the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) in a joint letter to the Drug Enforcement Administration (DEA), Substance Abuse and the Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services...
ASAM Releases Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment
Addiction Medicine Updates

ASAM Releases Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment

FOR IMMEDIATE RELEASE January 19, 2024   Rockville, MD – To facilitate remission, support long-term recovery, and save more lives of those affected by addiction, the American Society of Addiction Medicine (ASAM) today released a new Public Policy Statement on Government Strategies to Foster Ethical Addiction Treatment, with several recommendations for policymakers at all levels in...
Georgia will be 1st state to allow pharmacies to sell medical marijuana
Addiction Medicine Updates Articles of Interest

Georgia will be 1st state to allow pharmacies to sell medical marijuana

ATLANTA (AP) — Georgia soon will become the first state in the nation to offer medical marijuana products at independent pharmacies, state officials said. The Georgia Board of Pharmacy began accepting applications this week, and nearly 120 pharmacies have agreed to provide medication from Botanical Sciences, one of the state’s two licensed production companies, The Atlanta...
Addiction Medicine Updates Articles of Interest Legislation

The Modernizing Opioid Treatment Access Act: A Helpful Explanation

Synopsis:  The importance of responsibly expanding access to methadone treatment for opioid use disorder (OUD) is crucial. Methadone, a long-lasting opioid agonist, is a well-studied and effective medical treatment for OUD, which is associated with a significantly higher risk of early death. While there is support for liberalizing access to methadone from opioid treatment programs...
Bye-bye X-Waiver
Addiction Medicine Updates Legislation

Bye-bye X-Waiver

Dear Registrants: On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA Waiver Program.” DEA fully supports this significant policy reform. ln this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing...
The X Waiver Is Officially Dead
Addiction Medicine Updates Articles of Interest

The X Waiver Is Officially Dead

— But now, doctors will have to take substance use disorder training to get their DEA license by Amanda D’Ambrosio, Enterprise & Investigative Writer, MedPage, January 5, 2023 The Biden administration’s recent spending billopens in a new tab or window contained under-the-radar changes for addiction medicine, including eliminating the X waiver requirement for clinicians...
SAMSHA-Recruiting-Reviews
Addiction Medicine Updates

SAMSHSA Recruiting Peer Reviewers for Funding Opportunities

Dear Colleague, The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Division of Grant Review is recruiting new Peer Reviewers for our funding opportunities in mental health services and substance abuse prevention and treatment. Our Peer Reviewers evaluate grant applications through a fair, equitable and objective review process to provide SAMHSA and grant...
Addiction Medicine Updates Articles of Interest Legislation White Papers

ASAM’s Public Policy Statement on Regulation of Opioid Use Disorder Treatment

Public Policy Statement on the Regulation of the Treatment of Opioid Use Disorder with Methadone  Excerpt: The treatment of opioid use disorder (OUD) with methadone has a long history and robust scientific evidence supporting its effectiveness. Currently, U.S. federal law limits its availability to certified, accredited, and heavily regulated opioid treatment programs (OTPs), a...
Addiction Medicine Updates Articles of Interest

SAMHSA Proposes New Rules to Expand Access to Treatment

The Substance Abuse and Mental Health Services Administration (SAMHSA) proposed new rules to expand access to treatment for opioid use disorder (OUD), in particular with methadone through opioid treatment programs (OTPs).  The proposed changes will provide greater autonomy to OTP practitioners, as well as expand on telehealth and take-home flexibilities initially granted in connection...